Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Reprod Health ; 18(1): 132, 2021 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-34174905

RESUMEN

BACKGROUND: Antenatal screening for HIV, syphilis and HBV has been successfully implemented in The Netherlands, but data on other STI among pregnant women or male partners are limited. Our objectives: (i) to assess the prevalence of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) among pregnant women and male partners, (ii) to identify risk factors for these STI during pregnancy, and (iii) to identify adverse perinatal outcomes (APO) associated with STI. METHODS: Cross-sectional study. Pregnant women aged ≤ 30 years (n = 548) and male partners (n = 425) were included at 30 midwifery practices during 2012-2016. Participants provided a self-collected vaginal swab (women) or urine sample (men) and completed a questionnaire. Perinatal data were derived from pregnancy cards. APO was defined as premature rupture of membranes, preterm delivery, low birthweight, stillbirth, neonatal conjunctival and respiratory infections. Data were analysed by logistic regression. RESULTS: STI were present in 2.4% of pregnant women (CT 1.8%, NG 0.4%, TV 0.4%), and in 2.2% of male partners (CT 2.2%, NG 0.2%, TV 0%). Of young women (≤ 20 years), 12.5% had a CT infection. Prevalent STI during pregnancy was associated with female young age (≤ 20 years vs ≥ 21 years) (adjusted OR 6.52, CI 95%: 1.11-38.33), male non-Western vs Western background (aOR 9.34, CI 2.34-37.21), and female with ≥ 2 sex partners < 12 months vs 0-1 (aOR 9.88, CI 2.08-46.91). APO was not associated with STI, but was associated with female low education (aOR 3.36, CI 1.12-10.09), complications with previous newborn (aOR 10.49, CI 3.21-34.25 vs no complications) and short duration (0-4 years) of relationship (aOR 2.75, CI 1.41-5.39 vs ≥ 5 years). Small-for-gestational-age was not associated with STI, but was associated with female low education (aOR 7.81, 2.01-30.27), female non-Western background (aOR 4.41, 1.74-11.17), and both parents smoking during pregnancy (aOR 2.94, 1.01-8.84 vs both non-smoking). CONCLUSIONS: Prevalence of STI was low among pregnant women and male partners in midwifery practices, except for CT among young women. The study could not confirm previously observed associations between STI and APO, which is probably due to low prevalence of STI, small study sample, and presumed treatment for STI.


Antenatal screening for HIV, syphilis and HBV has been successfully implemented in The Netherlands, but data on other STI among pregnant women or male partners are limited. Our objectives were: (i) to assess the prevalence of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) among pregnant women and male partners, (ii) to identify risk factors for these STI during pregnancy, and (iii) to identify adverse perinatal outcomes (APO) associated with STI.Pregnant women aged ≤ 30 years and male partners were included at 30 midwifery practices. Women provided a vaginal swab, partners a urine sample; both completed a questionnaire. Perinatal data were derived from midwives.STI were present in 2.4% of pregnant women (CT 1.8%, NG 0.4%, TV 0.4%), and in 2.2% of male partners (CT 2.2%, NG 0.2%, TV 0%). Of women ≤ 20 years, 12.5% had a CT infection. Prevalent STI during pregnancy was associated with female young age, male non-Western background, and female with ≥ 2 sex partners < 12 months. APO was not associated with STI, but was associated with female low education, complications with previous newborn, and short duration of the relationship. Small-for-gestational-age was not associated with STI, but was associated with female low education, female non-Western background, and both parents smoking during pregnancy.Prevalence of STI was low among pregnant women and male partners in midwifery practices, except for CT among young women. The study could not confirm previously observed associations between STI and APO. Probably due to low prevalence of STI, small study sample, and presumed treatment for STI.


Asunto(s)
Infecciones por Chlamydia/epidemiología , Chlamydia trachomatis/aislamiento & purificación , Gonorrea/epidemiología , Neisseria gonorrhoeae/aislamiento & purificación , Complicaciones Infecciosas del Embarazo/microbiología , Tricomoniasis/epidemiología , Trichomonas vaginalis/aislamiento & purificación , Adolescente , Adulto , Infecciones por Chlamydia/diagnóstico , Estudios Transversales , Femenino , Gonorrea/diagnóstico , Humanos , Recién Nacido , Masculino , Partería , Países Bajos/epidemiología , Parto , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Mujeres Embarazadas , Prevalencia , Factores de Riesgo , Enfermedades de Transmisión Sexual/epidemiología , Enfermedades de Transmisión Sexual/microbiología , Tricomoniasis/diagnóstico , Adulto Joven
2.
Int J STD AIDS ; 31(9): 866-875, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32623979

RESUMEN

This paper evaluates correlates of trichomoniasis among female sex workers who inject drugs (FSWIDs) in two Mexico-US border cities. HIV-negative FSWIDs aged 18 years or older were enrolled in a study between 2008 and 2010 in Tijuana and Ciudad Juarez (Cd.), Mexico. All participants underwent a baseline interviewer-administered survey and did a rapid test for trichomoniasis. Using regression to estimate prevalence ratios, we examined sociodemographics, sex work characteristics, sexual health and behavior, substance use, and police and violence exposures as potential correlates of trichomoniasis. Of 584 women (284 in Tijuana, 300 in Cd. Juarez), prevalence of trichomoniasis was 33.6%. Factors associated with trichomoniasis in multivariable analysis were having money stolen by police in the past six months (adjusted prevalence ratio [aPR] =1.448, 95% confidence interval [CI] = 1.152-1.821), recent methamphetamine use (aPR = 1.432, CI = 1.055-1.944), lifetime syphilis infection (aPR = 1.360, CI = 1.061-1.743), ever use of a home remedy to treat vaginal symptoms (aPR = 1.301, CI = 1.027-1.649), and number of regular clients in the past month (aPR = 1.006 per client, CI = 1.004-1.009), while controlling for age and city of interview. Alongside the need for trichomoniasis surveillance and treatment programs, findings indicate that both structural and behavioral factors serve as primary correlates of trichomoniasis among FSWIDs in these cities.


Asunto(s)
Metanfetamina/efectos adversos , Trabajo Sexual , Trabajadores Sexuales/estadística & datos numéricos , Abuso de Sustancias por Vía Intravenosa/epidemiología , Tricomoniasis/epidemiología , Violencia/estadística & datos numéricos , Adolescente , Adulto , Femenino , Humanos , México/epidemiología , Factores de Riesgo , Tricomoniasis/diagnóstico , Estados Unidos/epidemiología , Sexo Inseguro/estadística & datos numéricos
3.
MMWR Recomm Rep ; 64(RR-03): 1-137, 2015 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-26042815

RESUMEN

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30-May 2, 2013. The information in this report updates the Sexually Transmitted Diseases Treatment Guidelines, 2010 (MMWR Recomm Rep 2010;59 [No. RR-12]). These updated guidelines discuss 1) alternative treatment regimens for Neisseria gonorrhoeae; 2) the use of nucleic acid amplification tests for the diagnosis of trichomoniasis; 3) alternative treatment options for genital warts; 4) the role of Mycoplasma genitalium in urethritis/cervicitis and treatment-related implications; 5) updated HPV vaccine recommendations and counseling messages; 6) the management of persons who are transgender; 7) annual testing for hepatitis C in persons with HIV infection; 8) updated recommendations for diagnostic evaluation of urethritis; and 9) retesting to detect repeat infection. Physicians and other health-care providers can use these guidelines to assist in the prevention and treatment of STDs.


Asunto(s)
Enfermedades de Transmisión Sexual/terapia , Terapias Complementarias , Condiloma Acuminado/terapia , Consejo , Femenino , Gonorrea/terapia , Infecciones por VIH/complicaciones , Hepatitis C/diagnóstico , Humanos , Masculino , Tamizaje Masivo , Mycoplasma genitalium/patogenicidad , Técnicas de Amplificación de Ácido Nucleico , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus , Recurrencia , Enfermedades de Transmisión Sexual/prevención & control , Personas Transgénero , Tricomoniasis/diagnóstico , Uretritis/diagnóstico , Uretritis/microbiología , Uretritis/terapia , Cervicitis Uterina/microbiología , Cervicitis Uterina/terapia
4.
J R Soc Health ; 117(6): 351-4, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9519671

RESUMEN

Generally, people tend to associate the phrase 'sexually transmitted diseases' (STDs) with only gonorrhoea and syphilis. This paper highlights the prevalence of other diseases such as herpes simplex, trichomoniasis and candidiasis which are also sexually transmitted. It is shown that, although they are rarely discussed and reported, various estimates, particularly in the developed countries where statistics are available, indicate that their incidence rates are rapidly rising to epidemic proportions and, in certain instances, have surpassed the annual cases of syphilis and gonorrhoea. Their causative organisms, mode of spread, signs and symptoms, complications, prevention and control are presented. Although knowledge of the above are important, it is emphasised that it is much more desirable to focus on prevention through public health education. Health education strategies such as avoiding sexual exposure with infectees, personal hygiene, simulation, role-play and unemotional discussion in schools and the use of mass media in disseminating information to the public regarding prevention, control and how to seek for treatment are elaborated upon.


Asunto(s)
Educación en Salud , Enfermedades de Transmisión Sexual/clasificación , Actitud Frente a la Salud , Candidiasis Vulvovaginal/diagnóstico , Candidiasis Vulvovaginal/prevención & control , Candidiasis Vulvovaginal/transmisión , Países Desarrollados/estadística & datos numéricos , Brotes de Enfermedades , Femenino , Enfermedades de los Genitales Femeninos/diagnóstico , Enfermedades de los Genitales Femeninos/parasitología , Enfermedades de los Genitales Femeninos/prevención & control , Enfermedades de los Genitales Masculinos/diagnóstico , Enfermedades de los Genitales Masculinos/parasitología , Enfermedades de los Genitales Masculinos/prevención & control , Gonorrea/transmisión , Promoción de la Salud , Herpes Genital/diagnóstico , Herpes Genital/prevención & control , Herpes Genital/transmisión , Humanos , Higiene , Incidencia , Masculino , Medios de Comunicación de Masas , Prevalencia , Desempeño de Papel , Educación Sexual , Conducta Sexual , Enfermedades de Transmisión Sexual/diagnóstico , Enfermedades de Transmisión Sexual/prevención & control , Sífilis/transmisión , Tricomoniasis/diagnóstico , Tricomoniasis/prevención & control , Tricomoniasis/transmisión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA